Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Clinical trial NCT03558997 · COMPLETED

Trial details

NCT number: NCT03558997
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2018-06-07
Primary completion: 2019-05-14
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.